Sintetica
Switzerland - MendriosiBiotechnology
Focus: Sintetica is a Swiss biotech (founded 1921) specializing in analgesics and anesthetics with a secondary focus on ophthalmology, operating as a mid-size organization with 201-500 employees.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Employees
201-500
Open Jobs
16
Should You Work at Sintetica?
AI assessmentSintetica offers stability and niche expertise in anesthetics, but opaque financials and modest hiring activity make it best suited for candidates seeking specialized experience over rapid career escalation.
Why Work Here
- Diversified pipeline in Phase 2–3 development across analgesics, anesthetics, and ophthalmic formulations signals active R&D momentum and potential clinical advancement opportunities
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
16 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Growth
Portfolio anchor with 5 Phase 2–3 trials across multiple indications and formulations driving clinical validation
Help build intelligence for Sintetica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.